Metabolic effects of anti-angiogenic therapy in tumors

► Multiple factors orchestrate tumor responses to VEGF neutralization. ► Glucose addiction dictates the amount of necrosis following anti-angiogenic therapy. ► The LKB1-AMPK pathway modulates tumor responses to anti-angiogenic drugs. ► Emerging technologies will uncover other metabolic changes caused by VEGF blockade.